Thank you for joining us at ad:tech tokyo !
Diamond Sponsor
※
：ad:tech appearance count
- Hardy Ts Kagimoto New
- HEALIOS K.K.
- MD, Chairman and CEO
Dr. Tadahisa “Hardy” Kagimoto, MD, is the Founder, Chairman and CEO of Healios K.K., a biotechnology company listed on the Tokyo Stock Exchange market Growth. Healios has grown into a world leader in the development of innovative, engineered iPSC derived therapies and leads the development of stem cell derived regenerative therapies to treat major areas of unmet medical need, including solid tumors, ischemic stroke, and acute respiratory distress syndrome. Prior to founding Healios, Dr. Kagimoto founded and ran as President and CEO Aqumen Biopharmaceuticals K.K., a biotechnology company that developed the de facto standard adjuvant used in eye surgery on a worldwide basis. Prior to founding Aqumen, Dr. Kagimoto was a clinical ophthalmologist after graduated from Kyushu University School of Medicine.